[Skip to Content]
[Skip to Content Landing]
Views 197
Citations 0
Correction
July 2018

Error in Figure 2

JAMA Ophthalmol. 2018;136(7):840. doi:10.1001/jamaophthalmol.2018.2864

In the Original Investigation titled “Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial,”1 published online May 2, 2018, the points indicating intravitreal aflibercept injection plus sham photodynamic therapy and intravitreal aflibercept injection plus active photodynamic therapy in panel A of Figure 2 were transposed. This article was corrected online.

References
1.
Lee  WK, Iida  T, Ogura  Y,  et al.  Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial [published online May 2, 2018].  JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2018.1804Google Scholar
×